MTNB
Matinas BioPharma Holdings Inc
NYSE MKT: MTNB · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.87% today
Updated 2026-04-29
Market cap
$3.91M
P/E ratio
—
P/S ratio
34.81x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Matinas BioPharma Holdings Inc (MTNB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $424364.00 | $11.33M | $3.36M | $8.41M | $9.82M | $14.42M | $19.94M | $40.24M | $70.97M | $61.33M | $78.87M | $25.10M | $12.64M |
| Cash & equivalents | $424364.00 | $10.84M | $2.59M | $3.23M | $4.11M | $7.31M | $12.45M | $22.17M | $12.43M | $21.03M | $6.88M | $4.79M | $7.28M |
| Current assets | $424364.00 | $10.92M | $2.81M | $3.56M | $4.57M | $7.96M | $13.09M | $29.92M | $61.55M | $50.99M | $34.53M | $15.54M | $8.03M |
| Total liabilities | $84427.00 | $858968.00 | $1.13M | $2.33M | $2.67M | $3.74M | $3.80M | $7.19M | $7.24M | $8.83M | $42.23M | $5.86M | $5.05M |
| Current liabilities | $84427.00 | $858968.00 | $1.12M | $1.13M | $1.44M | $2.22M | $2.84M | $3.10M | $3.57M | $4.35M | $4.29M | $2.62M | $2.67M |
| Long-term debt | — | — | $15000.00 | $16446.00 | $16000.00 | $67683.00 | $107656.00 | — | — | — | — | — | — |
| Shareholder equity | $339937.00 | $10.47M | $2.23M | $6.07M | $7.15M | $10.68M | $16.14M | $33.05M | $63.73M | $52.49M | $36.64M | $19.25M | $7.59M |
| Retained earnings | $-117592.00 | $-3.83M | $-14.05M | $-23.19M | $-35.18M | $-51.27M | $-65.94M | $-84.38M | $-107.51M | $-131.63M | $-152.63M | $-175.57M | $-199.82M |
| Accounts receivable | — | — | — | — | — | — | — | — | $650000.00 | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goodwill | — | — | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $1.34M | $0.00 |